The American Psychiatric Association and the Food and Drug Administration: an analysis and proposal for action
Abstract
The relationship between medicine and society is currently undergoing substantial change. While the Food and Drug Administration has no legal authority over the practicing physician, its decisions already influence medical practice. The Drug Regulation Reform Act of 1978, if passed in its present form, would grant FDA broad new powers over patient care and clinical research. In order to retain a high degree of control of its future and activities, the American Psychiatric Association must develop an effective mechanism for meeting this challenge and for serving the interests of its members and their patients. Dr. Alexander M. Schmidt comments on the author's presentation.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
